Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors

Abstract

loading...

About

This paper, published in 1950, received 253 indexed citations. Written by Mylyne Tham, Orhan Yılmaz, Mariam Alaverdashvili, Michael E. Kelly, Eileen M. Denovan‐Wright and Robert B. Laprairie covering the research area of Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology. It is primarily cited by scholars working on Pharmacology (230 citations), Cellular and Molecular Neuroscience (100 citations) and Cognitive Neuroscience (52 citations). Published in British Journal of Pharmacology.

Countries where authors are citing Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors

Since Specialization
Citations

This map shows the geographic impact of Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors more than expected).

Fields of papers citing Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1111/bph.14440.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026